Literature DB >> 24127318

Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications.

M Alcántara-Hernández1, C Torres-Zárate, G Pérez-Montesinos, F Jurado-Santacruz, M A Domínguez-Gómez, A Peniche-Castellanos, E Ferat-Osorio, N Neri, M J Nambo, I Alvarado-Cabrero, M Moreno-Lafont, S Huerta-Yepez, L C Bonifaz.   

Abstract

Mycosis fungoides (MF) is the most common variant of primary cutaneous T-cell lymphoma, and decreased forkhead box P3 (FoxP3) expression has been reported in MF late stages. Hypoxia-inducible factor 1 alpha (HIF-1α) may regulate FoxP3 expression; however, it is unknown whether HIF-1α is expressed in the CD4(+) T cells of MF patients and how it could affect the expression of FoxP3. Therefore, we evaluated the expression of HIF-1α and FoxP3 in CD4(+) T cells obtained from the skin lesions of MF patients. We found increased cell proliferation and an increase in CD4(+) T cells with an aberrant phenotype among early stage MF patients. HIF-1α was overexpressed in these CD4(+) T cells. In addition, we found a decrease in the percentage of FoxP3(+) cells both in the skin of MF patients, when compared with control skin samples, and with disease progression. In addition, a negative correlation was established between HIF-1α and FoxP3 expression. Skin HIF-1α expression in MF patients correlated with the extent of the affected area and increased with the disease progression. Finally, we showed that ex vivo inhibition of HIF-1α degradation increases the percentage of FoxP3(+) T cells in skin lesions. Our results suggest that overexpression of HIF-1α affects the levels of FoxP3 in MF patients, which could have relevant implications in terms of disease outcome.
© 2013 UICC.

Entities:  

Keywords:  FoxP3; cutaneous T-cell lymphoma; hypoxia inducible factor 1 alpha; mycosis fungoides

Mesh:

Substances:

Year:  2013        PMID: 24127318     DOI: 10.1002/ijc.28546

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

Review 1.  Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.

Authors:  Vinit Kumar; Dmitry I Gabrilovich
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

2.  EGFR-AS1/HIF2A regulates the expression of FOXP3 to impact the cancer stemness of smoking-related non-small cell lung cancer.

Authors:  Haolong Qi; Shanshan Wang; Juekun Wu; Shucai Yang; Steven Gray; Calvin S H Ng; Jing Du; Malcolm J Underwood; Ming-Yue Li; George G Chen
Journal:  Ther Adv Med Oncol       Date:  2019-06-13       Impact factor: 8.168

3.  NLRP3 Regulates IL-4 Expression in TOX+ CD4+ T Cells of Cutaneous T Cell Lymphoma to Potentially Promote Disease Progression.

Authors:  Enrique Huanosta-Murillo; Marcela Alcántara-Hernández; Brenda Hernández-Rico; Georgina Victoria-Acosta; Patricia Miranda-Cruz; María Antonieta Domínguez-Gómez; Fermín Jurado-Santacruz; Genaro Patiño-López; Vadim Pérez-Koldenkova; Alam Palma-Guzmán; Paula Licona-Limón; Ezequiel M Fuentes-Pananá; Alicia Lemini-López; Laura C Bonifaz
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.